Skip to main content

Charles River Laboratories International

Charles River Laboratories International Inc is an American contract research organization providing pre-clinical drug discovery and safety assessment services to the pharmaceutical industry. The company operates through three segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions, offering laboratory animal models, safety pharmacology, biologics testing, and endotoxin detection. Principal revenue streams derive from fee-for-service research contracts, animal model sales, testing kits, and clinical trial support agreements. Core end markets serve biopharmaceutical corporations, biotechnology startups, academic research institutions, and government health agencies globally. Charles River Laboratories holds the world-leading market share position in pre-clinical laboratory animal research models and safety testing services. The corporation is headquartered in Wilmington, Massachusetts, and its common stock trades on the New York Stock Exchange.

21 of the funds FundTelligence covers report a position in Charles River Laboratories International.

Legal name
CHARLES RIVER LABORATORIES INTERNATIONAL INC
Sector
Health Care
Country
United States
Funds holding it
21

Funds holding Charles River Laboratories International

Showing the 8 largest of 21 funds holding it.

Loading...